Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.210
+0.010 (0.24%)
Apr 29, 2026, 7:01 AM EDT - Market open

IMDX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
135215402138200
Upgrade
Market Cap Growth
70.35%436.55%94.02%-45.76%-80.98%24.52%
Upgrade
Enterprise Value
127199411414162
Upgrade
Last Close Price
4.207.502.382.506.4243.40
Upgrade
PS Ratio
33.3253.0221.3013.7439.7491.06
Upgrade
PB Ratio
--6.83-3.260.810.963.07
Upgrade
EV/Sales Ratio
31.3249.1821.649.6015.0773.75
Upgrade
Debt / Equity Ratio
-0.11-0.11-0.300.110.090.09
Upgrade
Debt / EBITDA Ratio
0.010.010.010.00--
Upgrade
Net Debt / Equity Ratio
0.260.260.41-0.26-0.43-0.43
Upgrade
Net Debt / EBITDA Ratio
0.290.290.230.320.721.44
Upgrade
Net Debt / FCF Ratio
0.320.320.230.280.340.74
Upgrade
Asset Turnover
0.130.130.030.020.010.02
Upgrade
Inventory Turnover
4.094.09----
Upgrade
Quick Ratio
1.051.051.411.381.852.50
Upgrade
Current Ratio
1.271.271.621.492.112.77
Upgrade
Return on Equity (ROE)
---910.86%-76.26%-35.52%-88.37%
Upgrade
Return on Assets (ROA)
-62.66%-62.66%-26.42%-15.91%-13.88%-13.82%
Upgrade
Return on Capital Employed (ROCE)
-222.90%-222.90%-83.60%-32.90%-32.80%-16.30%
Upgrade
Earnings Yield
-37.17%-23.36%-151.40%-134.52%-191.48%-32.03%
Upgrade
FCF Yield
-18.78%-11.80%-52.92%-114.30%-131.09%-19.08%
Upgrade
Buyback Yield / Dilution
-133.16%-133.16%-70.84%-38.10%-24.61%-35.80%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.